| Center for Regenerative Therapies Dresden (CRTD) | |
|---|---|
| Name | Center for Regenerative Therapies Dresden (CRTD) |
| Established | 2006 |
| Type | Research institute |
| Affiliation | Technische Universität Dresden; University Hospital Carl Gustav Carus Dresden |
| Location | Dresden |
| Director | Georg D. Rath (example) |
| Staff | ~200 researchers |
Center for Regenerative Therapies Dresden (CRTD)
The Center for Regenerative Therapies Dresden (CRTD) is an interdisciplinary research institute based in Dresden focused on stem cell science, tissue engineering and regenerative medicine. As a joint initiative integrating groups from Technische Universität Dresden and the University Hospital Carl Gustav Carus, the CRTD serves as a focal point for translational research linking basic biology to clinical applications within Saxony and the wider Germanyn biomedical ecosystem.
The CRTD's mission is to advance understanding of stem cell biology and regenerative processes and to translate discoveries into therapeutic strategies for degenerative and genetic diseases. Its aims include fostering interdisciplinary collaboration among departments of the Technische Universität Dresden (TU Dresden), promoting academic–industry partnerships with biotechnology firms in the BioValley and Saxon life-science clusters, and training scientists and clinicians in translational research. The centre positions itself at the intersection of basic research in cell biology and applied development in clinical trials and biotechnology.
Founded in 2006 as part of TU Dresden's strategic investments in life sciences, the CRTD grew from a consolidation of developmental biology, molecular medicine and clinical departments. Early funding combined federal German research grants and Saxon state support, with subsequent competitive awards from the Deutsche Forschungsgemeinschaft and European research programmes such as the European Research Council. Over the 2010s the CRTD expanded laboratory space and recruited internationally recognized investigators, contributing to TU Dresden's elevation to a University of Excellence profile. Its development mirrored Dresden's transformation into a regional centre for nanotechnology, optics and life sciences.
CRTD research spans pluripotent and adult stem cell biology, organoid models, gene-editing approaches (including CRISPR-Cas9), and biomaterials for tissue repair. Programmatic areas include cardiovascular regeneration, neuroregeneration, hepatic and pancreatic disease modeling, and skeletal tissue engineering. The centre emphasizes disease modeling using patient-derived induced pluripotent stem cells (iPSCs) and high-content screening platforms developed in collaboration with TU Dresden's Faculty of Medicine and the TU Dresden Center for Molecular and Cellular Bioengineering. Cross-cutting technology platforms at CRTD include single-cell transcriptomics, advanced imaging (confocal and lightsheet microscopy), and proteomics pipelines interfaced with the university's core facilities.
Located on the TU Dresden campus adjacent to the University Hospital Carl Gustav Carus, the CRTD operates BSL-2/3 cell culture suites, clean rooms for biomaterial fabrication, and shared animal facilities. The centre collaborates closely with Dresden research institutions such as the Max Planck Institute for Molecular Cell Biology and Genetics (MPI-CBG), the Fraunhofer Society institutes in Dresden, and the German Center for Neurodegenerative Diseases (DZNE) site. Industry partnerships include local biotechnology companies and national pharmaceutical partners for preclinical testing. CRTD teams participate in regional innovation networks that link with the Dresden University of Technology (TU Dresden) Biotechnology Cluster and the Saxony Innovation Center, strengthening technology transfer and commercialization pathways.
CRTD contributes to graduate and postgraduate education through doctoral programs and structured PhD training embedded in TU Dresden's International Graduate School for Biomedical Sciences. The centre supervises MD/PhD candidates and offers hands-on courses in stem cell techniques, animal models, and translational research methodology. Visiting scholar schemes and international fellowships attract researchers from Europe, North America and Asia, enhancing Dresden's profile as a training hub. Outreach activities include public lectures and participation in city science events to communicate regenerative medicine developments to the broader Dresden community.
A core objective of CRTD is clinical translation of lab discoveries. The centre supports preclinical validation pipelines and regulatory strategy development in collaboration with the University Hospital Carl Gustav Carus clinical departments to advance cell- and gene-based therapies into early-phase clinical trials. Several CRTD-originated technologies have led to spin-off companies and patent filings in areas such as iPSC-derived cardiomyocytes, biomaterial scaffolds and gene-correction platforms. These entrepreneurial outcomes contribute to Dresden's life-science economy and link academic innovation to regional biotechnology investment and healthcare improvements.
Category:Research institutes in Germany Category:Stem cell research Category:Technische Universität Dresden